Why Traditional Tests Fall Short
Historically, only patients who have diplopia or severe eye misalignment are identified as needing binocular vision care. But out of the approximately 42 million people in the US who visit an optometrist every year, an estimated 10 million of them have undiagnosed BVD. That's a lot of patients who are suffering daily from migraines, motion sickness, chronic neck pain, and anxiety.
Mainstream phoria tests such as Von Graefe phorias, vertical vergence, fixation disparity or near point of convergence are able to identify the 1/3 of BVD patients who have larger eye misalignment issues but most often miss the 2/3 of BVD patients who have more subtle misalignments. For decades, we have needed something that can better predict if a patient has a phoria and the likelihood that they would respond to treatment.
Introducing the BVDQ: A Powerful Tool for Identifying BVD
This is where the BVDQ™ comes in. This innovative, validated screening tool is specifically designed to help optometrists like you identify people who are suffering from the traditional as well as the non-traditional symptoms of Binocular Vision Dysfunction and who need help.
Over 50,000 patients have completed the BVDQ™, and it only takes 5 minutes to complete. It is simple to use and gives you accurate results in minutes, allowing you to identify people with previously overlooked but impactful BVD symptoms. With good data, you can confidently recommend the next steps in their care to overcome their symptoms and improve their lives. Patients who score above the symptom threshold on the BVDQ™ can benefit from a proper NeuroVisual exam and a pair of microprism lenses to relieve their symptoms.